A. Herbert, R. Schreiber, D. Glaab, and L. Eichenfeld, “Phase IV Evaluation of the Adrenal Suppression Potential and PKPD of Halobetasol Propionate Foam, 0.05% in Adolescent Subjects with Plaque Psoriasis”, J of Skin, vol. 5, no. 6, p. s47, Nov. 2021.